[Home ] [Archive]    
Main Menu
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: year 15, Issue 62 (2-2024) ::
3 2024, 15(62): 66-90 Back to browse issues page
- New Diagnostic Tests for Cardiovascular Diseases
Elham Rasodli 1, Habib Zeyghami2
1- Zanjan University of Medical Sciences, Zanjan
2- Zanjan University of Medical Sciences, Zanjan, Iran
Abstract:   (856 Views)
Introduction and Methods: Cardiovascular disease (CVD) is one of the main causes of death worldwide, and its prevalence continues to increase compared to previous decades due to the aging of the world population. Hospital cases of CVD, which are a critical health concern in low- and middle-income countries, are increasing every year. Primary prevention of CVD depends primarily on the ability to identify at-risk individuals before overt events development. This highlights the need for accurate risk stratification. Risk assessment is important to identify at-risk individuals who require immediate attention, as well as to guide the intensity of medical treatment to reduce subsequent CVD risk. There is a growing body of clinical research aimed at identifying these individuals by searching for biomolecules. Advances related to CVD in the past 30 years, as well as scientific advances in biomarker research, have led to more sensitive screening methods, greater emphasis on diagnosis, early detection of these diseases, improved treatments, and more favorable clinical outcomes in society.
Results and discussion: A large number of new biomarkers have been identified for predicting cardiovascular events, and these markers play an important role in defining, predicting and deciding on the management of cardiovascular events. This review of the clinical applications of classical and new biomarkers such as cardiac troponin (cTn), high-sensitivity troponin (cTn-hs), galectin-3 (Gal3), Source of Tumorigenicity2 (ST2), type B and C natriuretic peptide (BNP and CNP), growth differentiation factor 15 (GDF-15), myeloperoxidase (MPO), heart-type fatty acid-binding protein (H-FABP), high-sensitivity C-reactive protein (hsCRP), lipoprotein-associated phospholipase A2 (Lp-PLA2 ), microRNAs (miRNAs) and others have been discussed.

Keywords: Diagnostic Test, Cardiovascular Diseases
Full-Text [PDF 1498 kb]   (491 Downloads)    
Type of Study: Review | Subject: میکروب شناسی و باکتری شناسی
Received: 2024/03/11 | Accepted: 2024/03/11 | Published: 2024/03/11
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rasodli E, Zeyghami H. - New Diagnostic Tests for Cardiovascular Diseases. 3 2024; 15 (62) :66-90
URL: http://labdiagnosis.ir/article-1-568-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
year 15, Issue 62 (2-2024) Back to browse issues page
Laboratory and Diagnosis
Persian site map - English site map - Created in 0.05 seconds with 36 queries by YEKTAWEB 4657